These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33314720)

  • 21. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
    Romagnoli M; Mineva ND; Polmear M; Conrad C; Srinivasan S; Loussouarn D; Barillé-Nion S; Georgakoudi I; Dagg Á; McDermott EW; Duffy MJ; McGowan PM; Schlomann U; Parsons M; Bartsch JW; Sonenshein GE
    EMBO Mol Med; 2014 Feb; 6(2):278-94. PubMed ID: 24375628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
    Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N
    Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling.
    Wang T; Jin H; Hu J; Li X; Ruan H; Xu H; Wei L; Dong W; Teng F; Gu J; Qin W; Luo X; Hao Y
    J Exp Clin Cancer Res; 2020 Aug; 39(1):148. PubMed ID: 32746865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
    Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
    J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.
    Gossens K; Naus S; Holländer GA; Ziltener HJ
    PLoS One; 2010 Sep; 5(9):e12766. PubMed ID: 20856819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.
    Su Y; Guan XQ; Liu FQ; Wang YL
    Int J Mol Med; 2014 Sep; 34(3):842-8. PubMed ID: 24970008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
    Geng D; Zhao W; Feng Y; Liu J
    Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
    Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
    Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
    Liu C; Qu L; Zhao C; Shou C
    J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma.
    Ge JC; Wang YX; Chen ZB; Chen DF
    Cell Signal; 2020 Feb; 66():109465. PubMed ID: 31698037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
    Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
    Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.
    Chen CL; Wu JC; Chen GY; Yuan PH; Tseng YW; Li KC; Hwang SM; Hu YC
    Mol Ther; 2015 Jan; 23(1):79-88. PubMed ID: 25023326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.
    Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG
    Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
    Guaiquil VH; Swendeman S; Zhou W; Guaiquil P; Weskamp G; Bartsch JW; Blobel CP
    J Mol Med (Berl); 2010 May; 88(5):497-505. PubMed ID: 20119708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
    Zhang Y; Zha TZ; Hu BS; Jiang C; Ge ZJ; Zhang K; Tan YF
    Surgeon; 2013 Apr; 11(2):67-71. PubMed ID: 22878099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.